News and Updates

Sionna Therapeutics reports that its CF drug SION-719 failed to meet primary sweat chloride endpoints in a recent study. Read the latest clinical update here.

Haleon partners with Singapore’s A*STAR to launch a clinical study investigating metabolic health markers, aiming to improve wellness for Asian women.

City of Hope is transforming oncology research by decentralizing clinical trials. Discover how their new model improves equitable access to cancer care.

Sionna Therapeutics halts its SION-109 CF trial after failing to meet key endpoints, cementing Vertex Pharmaceuticals' lead in the cystic fibrosis market.

Discover the latest in pharma: RevMed and BeOne form a strategic Asian clinical trial partnership, while MoonLake celebrates a successful Phase 3 result.

Novo Nordisk removes a Catalent site from its FDA SMA drug filing to ensure regulatory success and streamline the path to market for its therapy.

Neurocrine Biosciences has launched Phase 1 trials for NBI-P'1968, a promising triple agonist targeting obesity. Learn about this new weight-loss approach.

NanoViricides receives Phase II approval for NV-387 oral gummies to treat Ebola. Learn how this innovative antiviral could reshape outbreak response.

Tenax Therapeutics’ heart failure drug, levosimendan, failed its pivotal Phase 3 trial. See the impact on PH-HFpEF treatment and the latest trial data.

WHO pushes for a Phase III trial of the Ervebo vaccine to combat the Bundibugyo Ebola outbreak. Discover the latest updates on this critical health move.